Standalone total income from operations of GSK Pharma rose to Rs 746.76 crore for the quarter under consideration from Rs 626.65 crore for the same period year-ago
GlaxoSmithKline Pharmaceuticals today reported 27.45 percent rise in its standalone net profit at Rs 128.67 crore for the third quarter ended September.
The company had posted a net profit of Rs 100.95 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.
Standalone total income from operations also rose to Rs 746.76 crore for the quarter under consideration from Rs 626.65 crore for the same period year-ago, it added.
The company follows January-December financial year. Established in 1924 in India, GlaxoSmithKline Pharmaceuticals' product portfolio includes prescription medicines and vaccines. The company's prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and
respiratory diseases.
Anda sedang membaca artikel tentang
GlaxoSmithKline Pharma Q3 net up 27% at Rs 128.67 crore
Dengan url
http://sehatgayahidup.blogspot.com/2014/11/glaxosmithkline-pharma-q3-net-up-27-at.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
GlaxoSmithKline Pharma Q3 net up 27% at Rs 128.67 crore
namun jangan lupa untuk meletakkan link
GlaxoSmithKline Pharma Q3 net up 27% at Rs 128.67 crore
sebagai sumbernya
0 komentar:
Posting Komentar